Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates.
about
Host Organelle Hijackers: a similar modus operandi for Toxoplasma gondii and Chlamydia trachomatis: co-infection model as a tool to investigate pathogenesisConserved type III secretion system exerts important roles in Chlamydia trachomatisStructure of a bacterial type III secretion system in contact with a host membrane in situStructure and Protein-Protein Interaction Studies on Chlamydia trachomatis Protein CT670 (YscO Homolog)The non-flagellar type III secretion system evolved from the bacterial flagellum and diversified into host-cell adapted systemsBioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatisKinematics of intracellular chlamydiae provide evidence for contact-dependent developmentMultifunctional analysis of Chlamydia-specific genes in a yeast expression system.Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model.The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex.Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropismChlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severityIdentification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis.A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.The Chlamydial Type III Secretion Mechanism: Revealing Cracks in a Tough Nut.Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.Biochemical and localization analyses of putative type III secretion translocator proteins CopB and CopB2 of Chlamydia trachomatis reveal significant distinctions.Chlamydia pneumoniae CopD translocator protein plays a critical role in type III secretion (T3S) and infectionThe Chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin and prevents microtubule assembly.A gatekeeper chaperone complex directs translocator secretion during type three secretion.Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARPSINC, a type III secreted protein of Chlamydia psittaci, targets the inner nuclear membrane of infected cells and uninfected neighborsChlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements.Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence FactorsApplication of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatisThe Type III Secretion System-Related CPn0809 from Chlamydia pneumoniaeChlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein.Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins.Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatisChlamydial Lytic Exit from Host Cells Is Plasmid Regulated.A working model for the type III secretion mechanism in Chlamydia.Pmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusionInduction of type III secretion by cell-free Chlamydia trachomatis elementary bodies.Role for the chlamydial type III secretion apparatus in host cytokine expression.Trafficking of chlamydial antigens to the endoplasmic reticulum of infected epithelial cells.Genus-optimized strategy for the identification of chlamydial type III secretion substrates.New frontiers in type III secretion biology: the Chlamydia perspective.Uncivil engineers: Chlamydia, Salmonella and Shigella alter cytoskeleton architecture to invade epithelial cells.Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease).Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis.
P2860
Q26825487-C78CD683-7053-4B41-B359-E9F8F70255CAQ26998512-CB3D07A6-5E59-4094-8CBA-2B7FFDEF97CEQ27340227-D0525A29-E3C8-4115-A224-E56B9737BBD9Q27660353-87052BF7-99B8-467F-8568-A654D9441196Q28276177-394604FD-8523-4C14-B167-87E352E3CF51Q28484742-4C33811C-FB8D-43AF-9CFE-A8938711B345Q30489992-371902D6-0907-42C1-91EE-8B05E5E50F2CQ31034927-9478D2E3-8A1D-49CE-8F07-ACE6049E7644Q33285974-6A34175D-4172-43F8-B0E6-95457F551551Q33502747-D2515929-A720-4442-A8B2-3930456E5CFDQ33565893-7CD9CD03-3806-46BC-931D-42C73F0E4E59Q33885417-9BA3C174-3CB5-4151-9965-FB3481695267Q34595020-3EDA917B-6F78-4027-B7C3-7D7DFF2E108CQ34980175-2E8F9BEB-B069-4927-B5BD-8031C8731454Q35075114-EE6E4583-2317-4AF7-9283-75E891A2EFA5Q35099063-83BA88B7-F94D-4E0A-AB7D-DE845117921CQ35139227-9BD01BF1-49E3-4ABE-BF11-7C73D2917819Q35193819-633B9308-8665-4170-9F95-2706B2439ECEQ35310949-47843212-9C66-4203-AB9D-8AD443FA841CQ35398859-67DD599C-8C68-474C-997F-F37CA9270132Q35545495-AB19A61A-3CA8-46C1-BD29-55FDC420A3E7Q35621978-8B769985-1920-4D24-B972-F6B3145A3500Q35634235-A43F0A66-755A-44A2-BD90-3622532C028FQ35710313-0289C286-D957-4A53-9AFC-CD62BADC27A4Q35741537-EE1E6891-877F-4F03-A21B-AC463FDFC23EQ35928664-B76DCF27-C635-49B6-A092-052616005A71Q35954456-DA9B9D7E-FD10-494C-BD88-D95756503389Q36201930-8559464F-A953-485E-B280-3CB62E27B1E0Q36281361-7370952B-98DA-4AAF-A2E6-5C8783E8ABBEQ36318962-1AC86E0A-7BA2-4081-BD3C-FDEF9134BC08Q36594034-A108659D-51F0-45F0-A3E8-8BA55A078220Q36845220-42073764-699A-4E8D-A1B5-ED686566641CQ36992556-8B2DDE30-CE02-4487-AC0D-5B5F0F114E75Q37032989-90C44AB0-052D-4937-8E6F-C63013552984Q37102940-2E4ECE19-154D-48D7-968D-9B8C1C290C94Q37337255-6AD8C9F0-3348-4297-A160-E34EEEE7CCAFQ37548120-07AE6822-91D7-4425-94EF-943F94D25447Q37781063-F9AB0A04-C456-43B0-A0C3-67BD65470AE0Q37844146-692DBD84-E7D4-4252-AE23-D9EC9BBC3896Q37846210-2A335FC2-C1B2-4B67-A7F9-B96E80E024FA
P2860
Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Analysis of putative Chlamydia ...... type III secretion substrates.
@ast
Analysis of putative Chlamydia ...... type III secretion substrates.
@en
Analysis of putative Chlamydia ...... type III secretion substrates.
@nl
type
label
Analysis of putative Chlamydia ...... type III secretion substrates.
@ast
Analysis of putative Chlamydia ...... type III secretion substrates.
@en
Analysis of putative Chlamydia ...... type III secretion substrates.
@nl
prefLabel
Analysis of putative Chlamydia ...... type III secretion substrates.
@ast
Analysis of putative Chlamydia ...... type III secretion substrates.
@en
Analysis of putative Chlamydia ...... type III secretion substrates.
@nl
P2093
P2860
P1476
Analysis of putative Chlamydia ...... type III secretion substrates
@en
P2093
David J Mead
Elizabeth R Fischer
Kenneth A Fields
P2860
P304
P356
10.1128/JB.187.18.6466-6478.2005
P407
P577
2005-09-01T00:00:00Z